Sun Pharma acquires EzeRx Health Tech in strategic move

Sun Pharmaceutical Industries Limited has disclosed its acquisition of EzeRx Health Tech Private Limited. The move reflects Sun Pharma's strategic expansion into the healthcare technology sector.

EzeRx operates in the pharmaceuticals and healthcare industry, specializing in non-invasive diagnostic and ancillary medical devices. While the acquisition is considered a non-material investment in allied areas, it marks Sun Pharma's strategic diversification into healthcare technology, aligning with the evolving healthcare landscape.

Sun Pharma has acquired EzeRx Health Tech, an early-stage medical technology company. EzeRx is known for its innovative non-invasive screening solutions that help identify primary health parameters early.

In the fiscal year 2022-23, EzeRx reported revenue from operations of Rs. 6.15 Crore. The acquisition was a cash consideration, with Sun Pharma investing Rs. 28.69 Crore. and acquired a 37.76% stake in EzeRx Health Tech. The acquisition is expected to be completed by October 2023, subject to the satisfactory fulfillment of certain conditions.